0001104659-19-051350.txt : 20190925 0001104659-19-051350.hdr.sgml : 20190925 20190925163045 ACCESSION NUMBER: 0001104659-19-051350 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190923 FILED AS OF DATE: 20190925 DATE AS OF CHANGE: 20190925 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coffin Robert CENTRAL INDEX KEY: 0001376492 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 191114544 MAIL ADDRESS: STREET 1: C/O BIOVEX GROUP, INC. STREET 2: 34 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 10801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-995-2443 MAIL ADDRESS: STREET 1: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 4 1 a4.xml 4 X0306 4 2019-09-23 0 0001737953 Replimune Group, Inc. REPL 0001376492 Coffin Robert C/O REPLIMUNE GROUP, INC. 18 COMMERCE WAY WOBURN MA 01801 1 1 0 0 President and CEO Common Stock 2019-09-23 4 S 0 24250 17.05 D 2387868 D The sale reported on this Form 4 was made by the reporting person pursuant to a trading plan adopted on March 7, 2019 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. Following the sale reported on this Form 4, the reporting person continues to beneficially own 2,387,868 shares of the Issuer's common stock. The reporting person also holds options to acquire 712,599 shares of the Issuer's common stock, 216,804 of which are exercisable as of the date hereof. /s/ Robert Coffin 2019-09-25